Submitted by Lawrence Jones, Ph.D. Biobuzz (October 16, 2018) reports “ By 2020, the general wound care market is expected to hit about $20.5 billion and that Maryland’s Gemstone Biotherapeutics aims to…
Read More
by Lawrence Jones, PhD On September 6, 2018, BioBuzz convened a CEO innovators discussion at the Columbus Center Baltimore Inner Harbor. Three successful entrepreneurial leaders in biotechnology professed an informative…
ForagerOne is a platform that recently launched at Hopkins to help students get involved in research. Search for faculty members university-wide doing research in the areas that interest you and then…
Written by JHU Alumnus Drew Bennett As covered previously in part 1 and part 2 of this “hypothetical yet educational” intellectual property story, Jack and Jill have several criteria to…
by Adil Agha Khan Johns Hopkins Alumnus’14 M.Sc. Candidate Biotechnology JHU ’19 I am a creative person, and I like to do it all. Being a natural scientist, I like…
by Johns Hopkins Alumnus Lawrence Jones, Ph.D. Christensen (1997) mentions that companies can stumble for several reasons however well managed companies always are competitively alert to their customers. The observation…
Mathias (August 10, 2018) reports that Alnylam Pharmaceuticals Inc’s drug for a rare hereditary disease won U.S. regulatory approval on Friday, August 10, 2018. This is newsworthy for the very…
by Johns Hopkins Alumnus Dr. Jeff Oster, Ph.D., J.D. This is an article for the Hopkins Bio Network to share experiences with fellow alumni who are considering taking the plunge…
Laser Microdissection Workshop: From Biology to Immuno-Oncology Aug 20-24, 2018 August 20 @ 8:00 AM – August 24 @ 5:00 PM « Apply for the Bio+Tech18 Pitch Contest by August…
Maryland, New York, Los Angeles, Boston, San Francisco The Hopkins Biotech Network (HBN) Affinity Group aims to enhance and create connections between alumni, current students, and the University to build…
